Debridement in Calciphylaxis: A Cautious, Selective Approach
Debridement can be performed in calciphylaxis wounds, but only selectively—aggressive surgical debridement of infected or draining wounds is associated with improved survival, while dry, stable eschars should NOT be debrided.
The Evidence-Based Approach
The most recent KDIGO guideline (2025) emphasizes that calciphylaxis requires a multimodal approach with specific attention to wound care as a critical nonpharmacotherapy intervention 1. However, the decision to debride is nuanced and depends entirely on wound characteristics.
When TO Debride
Surgical debridement is indicated when:
- Wounds show signs of infection or drainage
- Wet necrosis is present
- Eschar is separating or non-protective
- There is purulent material or clinical sepsis
The strongest evidence supporting debridement comes from a retrospective study showing 1-year survival of 61.6% in patients receiving surgical debridement versus only 27.4% in those who did not (P = 0.008) 2. This represents a dramatic mortality benefit when appropriately applied.
Multiple case series demonstrate successful outcomes with aggressive surgical approaches, including deep ulcer shaving combined with split-skin grafting achieving 30-90% graft take rates and complete healing in 6 of 7 patients 3. Another case achieved cure through staged debridement with dermal regenerative template placement 4.
When NOT to Debride
Debridement is contraindicated when:
- Dry, intact eschar is present without drainage
- No signs of infection exist
- The eschar is providing a protective barrier
This is critical: dry eschars in calciphylaxis serve as biological dressings protecting ischemic tissue beneath 5. Removing them exposes poorly perfused tissue to infection risk without healing potential.
The Clinical Algorithm
Assess wound characteristics first:
- Dry eschar + no drainage + no infection signs → Do NOT debride, maintain protective barrier
- Wet necrosis OR drainage OR infection signs → Proceed with debridement
If debriding, be aggressive:
- Deep shaving to viable tissue
- Consider same-session skin grafting or dermal templates
- Extensive debridement (even >30% body surface) has been successful 6
Combine with systemic management:
- Sodium thiosulfate therapy (though recent meta-analysis shows no proven benefit 1)
- Pain control (often requiring opioids)
- Correction of calcium-phosphate product
- Wound care optimization
Critical Pitfalls to Avoid
The most dangerous error is indiscriminate debridement of all necrotic tissue. Calciphylaxis wounds have extremely poor healing potential due to underlying vascular calcification and ischemia 5. Patients typically have multiple comorbidities (diabetes, obesity, renal failure) that further impair healing 2.
Removing protective dry eschar converts a stable wound into an open wound that cannot heal and becomes a portal for sepsis—the leading cause of death in calciphylaxis with mortality rates of 60-80% 4.
The Reality of Outcomes
Even with optimal management, calciphylaxis carries a 1-year survival of only 45.8% 2. The goal is infection prevention and pain management, not necessarily complete wound healing. Debridement decisions must weigh the survival benefit seen in infected wounds against the risk of converting stable wounds into lethal portals for sepsis.
Your decision framework: Infected/draining wound = debride aggressively. Dry stable eschar = leave alone and protect.